SSIEM Annual Symposium

Genetics meets Environment

1 – 4 September 2020 | Freiburg ∙ Germany

Welcome

Ute Spiekerkötter

Ute Spiekerkötter

President
Freiburg, Germany

“Our conference motto is “Genetics meets Environment“, focusing on different aspects of this exciting interplay. We have invited top-ranked speakers from various fields of research to stimulate discussion and to learn from each other.”

“Metabolic medicine has a long-standing tradition in Freiburg and its university is known for creative and innovative research in life sciences and technology. Freiburg therefore is the perfect host for the upcoming SSIEM conference in 2020.”

Young talents: At this meeting you shall meet the expert, but there will also be a special evening for young scientists to connect. Research needs new ideas and we especially invite young clinicians and researchers to Freiburg!”

Join us in Freiburg! The city, which is located in the Black Forest and just a stone’s throw away from Switzerland and France, is known for its historic buildings, the “Bächle“, and regional food and wine – and also for its early and ambitious environmental movement.”

Main Topics

Environment meets Metabolism

How do environmental factors influence health and disease and how does the microbiome modify phenotypes in metabolic diseases?

Genetics meets Metabolism

We will explore lessons learned from metabolomic profiling in large population studies and how this knowledge can be extrapolated to understand rare metabolic diseases.

Epigenetics meets Genetics

New findings in gene regulation and epigenetic mechanisms with special focus on “diet and disease” will be discussed.

Technology meets Metabolism

Transcriptome sequencing, next-generation newborn screening and computational modelling of inborn errors of metabolism will be explored.

Ethics meets Genetics

The ethical aspects of new technologies with respect to the use of data, data management, genetic results and gene editing will be addressed.

Reality meets Genetics

In this session, we will open the stage to patients and patient organisations. How can we all work together to promote precision medicine and individualised treatments?